UNSPSC 85723305: Replacement of left hip joint with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left hip joint with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SRB07Z

UNSPSC 85723305 Replacement of left hip joint with autologous tissue substitute, open approach is a Commodity code that shows little relevant recent state and local procurement activity. The recent opportunities posted under this code involve occupational medical surveillance, independent medical evaluations for pension disability determinations, surgical benefit management networks, pharmacy benefit administration, temporary health professional staffing, and emergency medical services for youth in custody — none of which involve orthopedic implant procurement or hip joint replacement procedures. The code's nominal scope (a specific surgical implant) does not align with what state and local bodies are actually soliciting under this tag in the current market.

The mismatch between the code's technical name and the actual solicitations suggests that either the opportunities are misclassified or the code is being used as a catch-all for broader healthcare procurement. No state or local issuing body in the recent-opportunities block is buying hip joint implants, prosthetics, or related surgical supplies. The mix of solicitations spans a city retirement board (Phoenix), two cities (Long Beach and Seattle area), a county (Collier), a county health system (Santa Clara), a state transportation agency (Washington Department of Transportation), and a county probation department (Harris County), but none relates to orthopedic device procurement. Given the absence of aligned recent opportunities, this code does not represent an active pursuit area for firms selling medical devices or implants to state and local buyers at this time.